Section Arrow
BSX.NYSE
- Boston Scientific Corp
Quotes are at least 15-min delayed:2025/08/24 18:18 EDT
Regular Hours
Last
 106.17
+0.96 (+0.91%)
Day High 
106.685 
Prev. Close
105.21 
1-M High
108.94 
Volume 
9.40M 
Bid
105.76
Ask
106.5
Day Low
105.42 
Open
105.71 
1-M Low
101.6 
Market Cap 
155.90B 
Currency USD 
P/E 62.63 
%Yield -- 
10-SMA 103.64 
20-SMA 104.47 
50-SMA 103.83 
52-W High 108.94 
52-W Low 78.53 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
1.68/3.37
Enterprise Value
165.26B
Balance Sheet
Book Value Per Share
15.13
Cash Flow
Cash Flow Yield
0.03
Income Statement
Total Revenue
16.75B
Operating Revenue Per Share
9.28
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
NXLNexalin Technology1.02+0.29+39.73%-- 
IINNInspira Technologies Oxy BHN Ltd1.17-0.08-6.40%-- 
BSXBoston Scientific Corp106.17+0.96+0.91%62.63PE
PACBPacific Biosciences of California1.38+0.12+9.52%-- 
QSIQuantum-Si1.14+0.03+2.70%-- 
Quotes are at least 15-min delayed:2025/08/24 18:18 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.